Per M. Johansson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus.
Journal: Acta ophthalmologica
Published: February 27, 2024
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.
Journal: PloS one
Published: February 23, 2022
Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline.
Journal: Biological psychiatry
Published: October 04, 2021
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: January 14, 2021
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: December 18, 2020
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease.
Journal: Translational psychiatry
Published: September 14, 2020
Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism - A pilot study.
Journal: Journal of clinical & translational endocrinology
Published: November 19, 2019
Apathy and anxiety are early markers of Alzheimer's disease.
Journal: Neurobiology of aging
Published: April 24, 2019
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.
Journal: Science translational medicine
Published: May 24, 2018
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 13, 2017
Last Updated: 09/26/2026